Skip to main content
Ariel Grajales-Cruz, MD, Hematology, Pembroke Pines, FL

Ariel F. Grajales-Cruz MD

Hematologic Oncology


Assistant Member

Join to View Full Profile
  • 603 N Flamingo RdSte 151Pembroke Pines, FL 33028

  • Phone+1 954-265-4325

  • Fax+1 954-436-4606

Dr. Grajales-Cruz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General Hospital
    University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General HospitalFellowship, Hematology and Medical Oncology, 2017 - 2020
  • VA Caribbean Healthcare System
    VA Caribbean Healthcare SystemChief Residency, Internal Medicine, 2016 - 2017
  • VA Caribbean Healthcare System
    VA Caribbean Healthcare SystemResidency, Internal Medicine, 2013 - 2016
  • Universidad Central del Caribe School of Medicine
    Universidad Central del Caribe School of MedicineClass of 2013

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2017 - 2027
  • PR State Medical License
    PR State Medical License 2015 - 2020
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular Therapies
    Ariel F Grajales-Cruz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Elotuzumab in Combination with an Immunomodulatory Agent (IMID) in Patients with Multiple Myeloma Refractory to Imids and/or Daratumumab: A Single-Institution Analysis... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Kellen O’Neill Walsh, MD, a Pediatric Resident with Children’s Mercy Hospital
    Kellen O’Neill Walsh, MD, a Pediatric Resident with Children’s Mercy HospitalSeptember 16th, 2021

Professional Memberships

Other Languages

  • French, Spanish

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: